Latest Market Expansion News

Felix Group Holdings Limited announces a strategic acquisition of Nexvia Pty Ltd to boost vendor monetisation and expand its SaaS platform capabilities, supported by a $16 million capital raise. The deal is expected to increase Felix’s pro-forma ARR by 38%, positioning the company for accelerated growth.

XRF Scientific Limited reported a record profit for FY25, driven by strong mining sector demand and international sales growth, alongside strategic acquisitions that bolster its market position.

XRF Scientific has reported a record full-year result for FY2025, with net profit rising 17% to $10.4 million and a 15% increase in its fully franked dividend. Strong global mining demand and recurring revenue streams underpin the company’s growth.

Rhythm Biosciences has announced a $3.75 million placement to accelerate the commercial launch of its ColoSTAT® cancer detection test and expand its geneType™ product suite into key markets. The capital raise includes director participation and attaching options, pending shareholder approval.

Adrad Holdings reported an 8.9% rise in FY25 sales revenue to $153.1 million despite a slight dip in EBITDA, while declaring a fully franked dividend and outlining strategic initiatives for FY26.

Lumos Diagnostics has submitted its CLIA waiver application for FebriDx® to the FDA, backed by strong clinical data and triggering significant milestone payments. Approval could expand the U.S. market opportunity fifteen-fold to over $1 billion.

Audeara Limited reports a strong start to FY26 with a 46% revenue increase driven by Australian wholesale growth and a key international partnership. The company’s global ambitions are further highlighted by multiple export award nominations.

EPX Limited has raised $2 million through a discounted share placement to existing institutional investors, aiming to fuel sales expansion, explore M&A opportunities, and enhance its technology platform.

Cochlear Limited has announced a fully franked ordinary dividend of AUD 2.15 per share for the six months ending June 2025, payable in October with multi-currency options for shareholders.

Phoslock Environmental Technologies prepares for ASX reinstatement with improved sales, factory refurbishment, and ongoing legal mediation.

HITIQ Limited has issued over 9.4 million shares and nearly 4.7 million options under its shortfall offer, raising $206,960 and progressing its ongoing rights issue. The company also clarified a duplicate filing and updated its issued capital structure.

Temple & Webster Group Limited has delivered a record FY25 with $601 million in revenue and a 43% jump in EBITDA, positioning itself strongly in the Australian furniture and homewares market. The company is on track to surpass $1 billion in annual revenue within the next few years.